Marketresearchnews

Friday, 20 March 2020

Anti-Fungal Agents Market, Segments, Growth And Value Chain 2019

Anti-fungal agents are used in the treatment of fungal infections. According to global action fund for fungal infection, globally, over 300 billion people of all ages suffer from a serious fungal infection every year.

The market drivers include rising prevalence of fungal infections, rising awareness, rise of immunity deficient population such as geriatrics, rise in exposure to infectious agents due to environmental factors such as pollution especially by particulates and agriculture residues and climatic conditions such as humidity and temperature, occupational hazards such as Jock itch, crowding etc. Growth of fungal infection due to off label use of broad spectrum antibiotics is a prime factor for the growing market for anti-fungal agents.

The market restraints include rising resistance to anti-fungal agents, use of air filters and air conditioning, excellent spectrum and efficacy of Azole class of anti-fungal agents, loss of patents and genericitization etc. Competition by generics is exceptionally strong and generics account for roughly 50% of total sales for anti-fungal agents. The market penetration is very easy as there has been loss of patents of block buster drugs. Over the counter drugs are an important reasons for the growth of anti-fungal agents market. The Middle East and Africa anti-fungal agents market is led by Azoles followed by Echinocandins. The Azole class is represented in the market by agents such as Noxafil, Vfend, and Diflucan.

Among the infections Dermatophytosis holds the majority share followed by candidiasis. The market leaders with considerable sales include fluconazole, terbinafine, voriconazole, itraconazole, and caspofungin.
Taking all factors into consideration, we expect the Middle East and Africa anti-fungal agents market to reach around $2.85 billion by 2022 from $2.32 billion in 2015, by the end of the forecast period at a CAGR of ~3.5%.
Study Objectives Middle East and Africa Anti-Fungal Agents Market:

To provide detail analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Middle East and Africa anti-fungal agents market
To provide insights about factors affecting the market growth
To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
To provide historical and forecast revenue of the market segments and sub-segments for Middle East and Africa anti-fungal agents market
To provide country level analysis of the market with respect to the current market size and future prospective
To provide country level analysis of the market for segments by product type, by construction material, by end users and other sub segments.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.

Intended Audience

Anti-fungal agents Manufacturers
Anti-fungal agents Suppliers
Private Research Laboratories
Research and Development (R&D) Companies
Market Research and Consulting Service Providers
Government Research Laboratories
Contract Manufacturing Organizations

Key Players for Middle East and Africa Anti-fungal agents Market:
Some of the key players in this market are: Novartis AG, Pfizer, Inc., Sanofi-Aventis, Merck & Co., Inc., Enzon Pharmaceuticals, Inc., Bayer AG, Astellas Pharma, Inc., GlaxoSmithKline plc, Abbott, Sigma-Aldrich and others.
Segments:

Middle East and Africa anti-fungal agents market has been segmented on the basis of therapeutic indication which comprises into aspergillosis, dermatophytosis, candidiasis and others. On the basis of drug class; market is segmented into azoles, pyrimidines, echinocandins, polyenes, allylamines, and others. On the basis of route of administration; market is segmented into oral, local and others.

Regional Analysis of Middle East and Africa Anti-fungal agents Market:

UAE is the largest market for anti-fungal agents in entire Middle East and Africa anti-fungal agents Market closely followed by Egypt. The rest of Africa market is however the fastest growing with a huge unmet medical needs and peculiar climatic conditions that support growth of fungal infections.

About Us

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Hepatitis C Drugs Market 2019 - Current And Future Plans 2023

Market Synopsis of Global Hepatitis C Drugs Market:

Hepatitis is inflammation of the liver characterized by yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting, poor appetite, joint pain, headaches, clay colored stools etc.

Hepatitis is caused by a variety of factors both microbial and non-microbial. However hepatitis C is caused by hepatitis C virus and affects between 130–150 million people globally every year of which approximately 700 000 people die from hepatitis C-related liver diseases. What is of greater concern is the fact that 15 to 20% of chronically infected patients develop liver cirrhosis or liver cancer.

The market for hepatitis C is driven by factors such as disease prevalence, rise in government subsidy and reimbursement especially in U.S., greater screening especially in developing nations, drug abuse and unsafe sex etc.
However the restraints are overwhelming such as self-imitating nature of the disease in a sizable number of patients, challenge of herbal treatment offered at negligible prices especially in developing regions, price war between companies such as between Gilead and Merck, rising urbanization and better sanitation etc. Thus the market in developed regions appears to reach a plateau as the number of people affected is not rising in developed regions. The reevaluation of hepatitis C strategy by companies such as Boehringer Ingelheim and its decision to refrain from moving forward in hepatitis C research also is an indication of stagnancy in developed region markets.
The market is also unitary with a few dominant players such as Gilead with a few brands such as Sovaldi, Harvoni etc are leading the market. The development pipeline is however strong in the vaccine segment and it is expected that a vaccine will make its foray in the near future as happened with other forms of hepatitis.

Taking into consideration all factors the market for global hepatitis drugs was estimated to rise from $18700 million to $22721.1 million by the end of forecasting period reflecting a sluggish CAGR of 3.3%.

Study Objectives Global Hepatitis C Drugs Market:

To provide detail analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the global Hepatitis C drugs market
To provide insights about factors affecting the market growth
To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
To provide country level analysis of the market with respect to the current market size and future prospective
To provide country level analysis of the market for segments by drug class (anti-viral, immuno-modulators and others), by medicine system (allopathic, alternative and others), by route of administration (oral, injectable and others) and by end user (hospitals and private)
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.

Key Players for Global Hepatitis C Drugs Market:

Some of the key players in this market are: Gilead sciences Inc., Abbvie Inc, Johnson & Johnson, Merck & co. Inc., Glaxosmithkline plc, Novartis AG, Bristol-Myers Squibb, Hoffmann-la Roche ltd. and others.

Segments:

Global hepatitis c drugs market has been segmented on the basis of drug class which comprises anti-viral, immuno-modulators and others. On the basis of medicine system; market is segmented into allopathic, alternative and others. On the basis of route of administration; market is segmented into oral, injectable and others. On the basis of end user the market is segmented into hospitals and private.

Regional Analysis of Global Hepatitis C Drugs Market:

Globally America is the largest market for Hepatitis C drugs. Europe is the second-largest market for Hepatitis C drugs. The developed regions market is expected to remain stagnant and even may show negative CAGR due to falling patient’s number. Thus market of developing nations however will show moderate growth and is expected to catch on the developed regions. The Asia pacific region will be led by China and India. Africa is expected to be a laggard in the global hepatitis C market.

Browse More Healthcare Reports @ https://www.marketresearchfuture.com/categories/healthcare-market-report

About Us

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Worldwide Microspheres Market 2019 Outlook, Top 10 Industry Players Comprehensive Analysis And Forecast To 2023

Market Scenario:

The Global Microspheres Market is growing rapidly. The growth of the market is majorly influenced by the various applications and advancements of microspheres in controlled drug delivery system. Other factors that are influencing this market are increasing advancement in drug development, increasing user of microspheres for clinical research and others. Globally the market of microspheres is expected to grow at a CAGR of about 11.9% till 2022 and the growth at this rate has started since 2016.

Key Players for Microspheres Market:

Some of the key players in this market are: 3M (Unites States), Potters Industries LLC (United States), AkzoNobel N.V. (Netherlands), Momentive Performance Materials Inc. (United States), Chase Corporation (United States), Matsumoto Yushi Seiyaku Company (Japan), Mo-Sci Corporation (United States), Trelleborg AB (Sweden), Luminex Corporation (United States) and others.

Study Objectives of the Market:

Providing a detail analysis of the market structure along with forecast for the next 7 years related to various segments and sub-segments of the Microspheres market.
Giving insights about factors affecting the market growth.

Analyzing the market based on price analysis, supply chain analysis, Porters Five Force analysis etc.

Giving the past revenue and estimated future revenue of the market’s segments and sub-segments with respect to the main market and various markets globally.
Giving regional level analysis of the market with respect to the current market size and future prospect.
Giving regional level analysis of the market with respect to segments, by material, by types, by application, also giving regional level analysis of the market’s sub-segments.

Providing an overview of key players and their strategic profiling in the market; comprehensively analyzing their core competencies and drawing the market’s competitive structure.

Tracking and analyzing competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments in the global Microspheres market.

Segments:

Global Microspheres market has been segmented on the basis of material which comprises synthetic polymers and natural polymers. On the basis of types the market is segmented into bioadhesive microspheres, magnetic microspheres, floating microspheres, radioactive microspheres, and polymeric microspheres. Furthermore on the basis of application the market is segmented into drug carriers, pulmonary drug delivery, tissue regeneration and others.

Intended Audience:
Pharmaceutical companies

Hospitals

Clinics

Academic research institutes

Government institutes

Regional Analysis of Microspheres Market:

North America is the largest market of global microspheres market. The North American market for microspheres is expected to grow at the CAGR of 11.3% from 2016 to 2022. Europe is the second largest market for Microspheres which is expected to grow at a CAGR of 11.5%. Asia Pacific region is expected to be fastest growing region of the global Microspheres market.

Browse More Healthcare Reports @ https://www.marketresearchfuture.com/categories/healthcare-market-report

About Us

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Biomarkers Market Research Report 2019 Analysis And Forecast To 2023

Biomarkers Market is projected to reach USD 40 Billion in 2018 and expected to register a 13.5% CAGR during the forecast period. Biomarkers are molecules that indicate normal or abnormal processes taking place in the human body and may be a sign of an underlying condition or disease. Various types of molecules, such as DNA, proteins, or hormones, can serve as biomarkers.

The primary factors driving the growth of global biomarkers market are increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, and high prevalence of cancer. According to The American Cancer Society, more than 1.7 million new cancer cases are expected to be diagnosed in 2019 in the Americas. According to the World Health Organization (WHO), more than 3.7 million new cases and 1.9 million deaths occur each year in Europe, and cancer represents the second most important cause of death and morbidity in Europe.

However, high capital investments and technical issues related to sample collection and storage are expected to restrain the growth of the market.

Segmentation
The Global Biomarkers Market has been segmented into Product, Type, Application, and Disease Indication.
By product, the market has been segmented into consumables, services, and software.
On the basis of type, the market has been segmented into safety biomarkers, efficacy biomarkers, and validation biomarkers. Efficacy biomarkers are further sub-segmented into predictive biomarkers, surrogate biomarkers, pharmacodynamic biomarkers, and prognostic biomarkers.
Based on application, the market has been segmented into diagnostics, drug discovery and development, personalized medicine, disease risk assessment, and other applications.
Based on disease indication, the market has been segmented into cancer, cardiovascular disorders, neurological disorders, immunological disorders, and other diseases.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The biomarkers market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.

The European Biomarkers market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The Biomarkers market in Asia-Pacific has been segmented into Japan, China, India, Latin Korea, Australia, and the rest of Asia-Pacific. The Biomarkers market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key Players

Qiagen N.V. (Germany), Perkinelmer, Inc. (US), Merck Millipore (US), Bio-Rad Laboratories, Inc. (US), Enzo Biochem, Inc. (US), EKF Diagnostics Holdings, Inc. (UK), Meso Scale Diagnostics, LLC (US), Biosims Technologies Sas (France), Cisbio Bioassays (France), and Signosis, Inc. (US) are some of the Key Players in the Global Biomarkers Market.

Browse More Healthcare Reports @ https://www.marketresearchfuture.com/categories/healthcare-market-report

About Us

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Digital pathology Market Volume Forecast And Value Chain Analysis 2019

Digital Pathology comprises an array of equipment capable of capturing, analyzing, interpreting, and managing digital information gained from slides. The technology is gaining focus rapidly thanks to its wide application in tissue-based research, human pathology, and drug development. Global Digital Pathology Market is expected to register a CAGR of 13.04% during the forecast period from 2018 to 2023 and expected to reach USD 8,305.6 MN by 2023.

The rise in the number of pathologists, benefits of digital pathology, and its rapid use in the healthcare sector are factors anticipated to drive market demand during the forecast period. Adoption of electronic health records (EHRs), integration of automation to expedite workflow, and technological improvements in image analysis software are other factors likely to influence the buying decisions of hospitals and clinics. But high implementation costs of digital pathology combined with stringent regulatory policies can act as roadblocks for the market.

Digital Pathology Market Report Overview

The report covers the latest trends affecting the market to provide the most accurate forecasts and predictions. By correlating the historical data with key market dynamics, our analysts make highly astute projections regarding the scope of the market and its future prospects. MRFR’s report includes a thorough analysis of the global digital pathology market segmented by type, product, application, end-user, and region. Trends and opportunities are highlighted coupled with the market share of companies as well as their valuation in the market. It analyzes new revenue sources for players and outlines the various strategies implemented by players.

Digital Pathology Market Segment

Types of digital pathology include human and animal pathology. Products in the digital pathology market includes software, hardware, and storage. Major applications include disease diagnosis, drug discovery, Mhealth, and telemedicine. In terms of end-users, the market is segmented into hospitals & clinics, research centers & academic institutes, and diagnostic centers.

The digital pathology market segments covered in the report are analyzed with respect to four major regions – The Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA), with respective country-level market sizing. The definition and advantages of “digital pathology” are outlined in the report for a comprehensive understanding of the market. The report discusses in minute detail the various players and the strategies outlined by them to enhance their value chain.
Digital Pathology Market Competitive Landscape

Noteworthy participants in the digital pathology market include Olympus Corporation (Japan), Danaher Corporation (Leica Biosystems GmbH) (U.S.), Inspirata (U.S.), 3DHISTECH Ltd. (Hungary), Huron Digital Pathology Inc. (Canada), Koninklijke Philips N.V. (The Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), microdimensions GmbH (Germany), Definiens (Germany), Mikroscan Technologies, Inc. (U.S.), among others.

The report offers comprehensive profiles on these digital pathology market players and assesses their current standing in the market. Company history coupled with annual turnover, profit margins, segmental share, SWOT analysis, growth strategies, expansion techniques, and latest R&D initiatives is discussed in minute detail.

Browse More Healthcare Reports @ https://www.marketresearchfuture.com/categories/healthcare-market-report

About Us

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Global Apheresis Market Production, Capacity, Revenue, Price, Gross Margin Analysis And Forecast 2019-2023

Apheresis is the medical technology which is used for the purification of the blood or separation of different component of blood. It involves removing of the blood from the donor or patients and collecting it into an apparatus which separates the desired component from the blood, while the rest of the blood is send back to the donor or patients. This separation of the component was done by two process namely centrifugation and filtration. Global apheresis market is driven by development in the new apheresis techniques and increasing prevalence of different chronic diseases, blood related diseases and many more. Increasing demand for the different component of the bloods, rising complex surgical procedures and increasing number of accidents across the globe has also contributed in the growth of the market. According to National Health Service (NHS) Blood and Transplant, the demand for platelets. While lack of skilled professional and Blood and blood product can be infected very easily, this risk of infection also contribute in hindering the market growth.

The market for apheresis is increasing at a rapid pace which is expected to grow at a CAGR of 10.2% during forecasted period 2017-2023.
Segmentation:

Global apheresis market is segmented on the basis of product into devices and disposables. Devices are further segmented into plasma separators, platelets separators and other. On the basis of procedures, they are plateletpheresis, leukapheresis, erythrocytapheresis, plasmapheresis and other. On the basis of methods they are centrifugation and filtration. Centrifugation is further segmented into continuous flow centrifugation, intermittent flow centrifugation and other. On the basis of application, the market is segmented into oncological diseases, renal diseases, cardiovascular diseases, haematological diseases, immunological diseases, neurological diseases and other and on the basis of end user they are blood banks, hospitals and other.

Study Objectives Global Apheresis Market:

Detail analysis of global apheresis market with region specific growth and competitive analysis on the basis of major players present in the market

Detail analysis of global apheresis market and different drivers and restraints affecting the growth of the market
Detailed analysis of the historical and forecasted market analysis of the market on the basis of factors like- price analysis, supply chain analysis, porters five force analysis etc.
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global apheresis
Detail analysis on the possible segments and sub segments of the market. And regional analysis of the market- Americas, Europe, Asia Pacific and Middle East and Africa.

Insights on the major countries/regions in which these major industries is flourishing and to also identify the untapped regions which could be the potential markets in future

Intended Audience

Apheresis manufacturers
Apheresis suppliers
Research and Development (R&D) Companies
Government Research Laboratories
Independent Research Laboratories
Government and Independent Regulatory Authorities
Market Research and Consulting Service Providers
Medical Research Laboratories
Academic Medical Institutes and Universities

Regional analysis:
On regional basis, Americas hold the largest share in the global apheresis market. Continuous advance in technology, increasing opportunity for apheresis products and presence of a huge number of people suffering from different chronic diseases has spurred the growth of this market in Americas. Europe is the second leading market which is followed by Asia Pacific. However Asia Pacific is the fastest growing region for the market. Increasing demand for different blood components for the patients, rapid development in healthcare and increasing healthcare expenditure are contributing in the growth of Asia Pacific apheresis market.
Key Players For Global Apheresis Market:

Asahi Kasei Medical Co. Ltd. (Japan), Fresenius Medical Care (Germany), Terumo BCT, Inc. (US), Haemonetics Corporation (US), Kawasumi Laboratories Inc. (Japan), HemaCare Corporation (US), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan), Cerus Corporation (US), B. Braun Melsungen AG (Germany), Nikkiso Ltd. (Japan), Therakos, Inc. (US).

Browse More Healthcare Reports @ https://www.marketresearchfuture.com/categories/healthcare-market-report

About Us

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Worldwide Menstrual Cup Market 2019 Outlook, Top 10 Industry Players Comprehensive Analysis And Forecast To 2023

The global Menstrual Cup market is anticipated to reach USD 1514.01 million by 2023, as per a new detailed report by Market Research Future (MRFR). It is expected to exhibit a 3.50% CAGR during the assessment period (2018-2023). The rise in the women populace coupled with high costs of sanitary pads and tampons are expected to drive Menstrual Cup market growth over the forecast period. Demand for eco-friendly feminine hygiene products can bode well for the market.

Menstrual Cup are an eco-friendly alternative to tampons or sanitary napkins derived from medical-grade silicone. The rise of the women workforce coupled with the female gender representing nearly half of the global population are factors expected to spur the Menstrual Cup market growth. In addition, the products can prevent leakage of menstrual fluids with no reported adverse effects.

Menstrual Cup Market Report Overview

This report allows the user to gain a deeper understanding of the ongoing events and trends in the global market for Menstrual Cup. By correlating the historical data with key market dynamics, our analysts were able to make highly accurate projections in the report. MRFR’s report includes a thorough segmental analysis of the global Menstrual Cup market segmented by product type, test type, end-user, and region with astute insights. This report has been prepared to assist industry participants in making informed decisions on growth strategies and operation management. Users will also come across drivers, trends, opportunities, and restraints which are likely to influence the growth of the Menstrual Cup market during the assessment period.

Menstrual Cup Market Players Covered

Me Luna, LadyCup, Ruby Life Ltd., Lunette, Irisana S.A., The Keeper, Inc., Vcup, Anigan, FemCap, Inc., and Diva International Inc., are prominent players in the Menstrual Cup market. These companies have turned to online channels and digital marketing to create their niche. Online channels offer privacy to users with consumers choosing to buy sanitary products at their own discretion.

Menstrual Cup Market Segment Overview

By product, the Menstrual Cup market has been segmented into reusable and disposable Menstrual Cup. Reusable cups will dominate the market by accounting for a large market share by 2023. This can be attributed owing to reusability cycle of these cups ranging from 1 to 5 years depending on the brand. By type, the market is segmented into hollow, pointy, flat, and round. The round segment accounted for 43% market share due to the flexibility in the design of these products.

By distribution channel, the market is segmented into online stores, retail outlets, and others. The online store channel segment accounted for 62% market share owing to penetration of e-commerce stores and changing buying patterns of consumers.

The segments and sub-segments covered in the report are analyzed under four major regions –Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA), with respective country-level market sizing. For the scope of research, the standard definition of the product/ service “Menstrual Cup” is included in the report. The report discusses and interprets the current and future opportunities of the industry by delivering an unbiased growth assessment.

The report offers comprehensive profiles on these market players and assesses their current standing in the Menstrual Cup market. Company history coupled with annual turnover, segmental share, SWOT analysis, growth strategies, new product launches, M&A activities, and latest R&D initiatives are outlined in the report.

About Us

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com